Mutual Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.95M | Buy |
45,543
+1,991
| +5% | +$191K | 0.08% | 229 |
|
|
2025
Q4 | $4.18M | Buy |
43,552
+850
| +2% | +$82.6K | 0.09% | 216 |
|
|
2025
Q3 | $4.02M | Buy |
42,702
+590
| +1% | +$54.2K | 0.09% | 223 |
|
|
2025
Q2 | $3.91M | Sell |
42,112
-32
| -0.1% | -$2.71K | 0.1% | 204 |
|
|
2025
Q1 | $3.55M | Sell |
42,144
-4,024
| -9% | -$360K | 0.1% | 193 |
|
|
2024
Q4 | $4.02M | Buy |
46,168
+5,190
| +13% | +$449K | 0.12% | 169 |
|
|
2024
Q3 | $3.73M | Sell |
40,978
-1,545
| -4% | -$130K | 0.11% | 171 |
|
|
2024
Q2 | $3.4M | Buy |
42,523
+3,483
| +9% | +$286K | 0.1% | 184 |
|
|
2024
Q1 | $3.4M | Buy |
39,040
+6,853
| +21% | +$585K | 0.11% | 176 |
|
|
2023
Q4 | $2.65M | Buy |
32,187
+4,331
| +16% | +$330K | 0.09% | 218 |
|
|
2023
Q3 | $2.18M | Sell |
27,856
-717
| -3% | -$60K | 0.09% | 223 |
|
|
2023
Q2 | $2.52M | Buy |
28,573
+548
| +2% | +$47.2K | 0.1% | 209 |
|
|
2023
Q1 | $2.26M | Buy |
28,025
+3,014
| +12% | +$246K | 0.09% | 219 |
|
|
2022
Q4 | $1.94M | Buy |
25,011
+283
| +1% | +$22.9K | 0.09% | 235 |
|
|
2022
Q3 | $2M | Buy |
24,728
+12,604
| +104% | +$1.13M | 0.1% | 192 |
|
|
2022
Q2 | $1.09M | Buy |
12,124
+575
| +5% | +$58.3K | 0.07% | 314 |
|
|
2022
Q1 | $1.28M | Buy |
11,549
+301
| +3% | +$31.8K | 0.07% | 303 |
|
|
2021
Q4 | $1.16M | Buy |
11,248
+436
| +4% | +$50.5K | 0.06% | 344 |
|
|
2021
Q3 | $1.35M | Buy |
10,812
+1,677
| +18% | +$217K | 0.08% | 293 |
|
|
2021
Q2 | $1.13M | Buy |
9,135
+363
| +4% | +$45.6K | 0.07% | 333 |
|
|
2021
Q1 | $1.04M | Sell |
8,772
-4,317
| -33% | -$506K | 0.07% | 318 |
|
|
2020
Q4 | $1.53M | Sell |
13,089
-2,684
| -17% | -$295K | 0.11% | 215 |
|
|
2020
Q3 | $1.64M | Buy |
15,773
+230
| +1% | +$23.1K | 0.14% | 168 |
|
|
2020
Q2 | $1.43M | Buy |
15,543
+8,864
| +133% | +$850K | 0.14% | 166 |
|
|
2020
Q1 | $602K | Buy |
6,679
+1,735
| +35% | +$185K | 0.08% | 254 |
|
|
2019
Q4 | $561K | Buy |
4,944
+206
| +4% | +$22.6K | 0.06% | 324 |
|
|
2019
Q3 | $515K | Buy |
4,738
+162
| +4% | +$16.9K | 0.07% | 302 |
|
|
2019
Q2 | $446K | Buy |
4,576
+410
| +10% | +$37.4K | 0.06% | 343 |
|
|
2019
Q1 | $379K | Sell |
4,166
-947
| -19% | -$84.8K | 0.06% | 315 |
|
|
2018
Q4 | $465K | Buy |
5,113
+2,310
| +82% | +$216K | 0.09% | 244 |
|
|
2018
Q3 | $276K | Buy |
+2,803
| New | +$259K | 0.04% | 385 |
|
Other funds holding MDT
VCM
VPM
Mutual Advisors's MDT Position: Q1 2026 in Review
Mutual Advisors increased its Medtronic (MDT) stake by 4.6% in Q1 2026, buying an estimated $191K and bringing the position to 45,543 shares worth $3.95M. The position accounts for 0.08% of the portfolio, ranked #229.
Mutual Advisors first reported a position in MDT in Q3 2018 and has held it in 31 quarters since. The position peaked at $4.18M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Mutual Advisors held 45,543 shares of Medtronic worth $3.95M as of Q1 2026.
- Mutual Advisors bought 1,991 Medtronic shares in Q1 2026, an estimated $191K.
- Medtronic made up 0.08% of Mutual Advisors's portfolio in Q1 2026, its #229 holding.
- Mutual Advisors first reported a position in Medtronic in Q3 2018 and has held it in 31 quarters since.
- Mutual Advisors's Medtronic position peaked at $4.18M in Q4 2025.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Mutual Advisors's 13F filing for Q1 2026, filed 4 May 2026.